Cargando…

How the EU animal welfare legislation can tackle AMR – a One Health perspective

The development of antimicrobial resistance (AMR) is linked to the imprudent use of antimicrobials and is fuelled by industrial farming, accounting for 70% of antimicrobial use. Tackling AMR requires a One Health approach that addresses the root causes of high antimicrobials use in intensive farming...

Descripción completa

Detalles Bibliográficos
Autores principales: Pegger, T, Haager, D, Jamal, N, Heidbuechel, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595174/
http://dx.doi.org/10.1093/eurpub/ckad160.081
_version_ 1785124806359777280
author Pegger, T
Haager, D
Jamal, N
Heidbuechel, K
author_facet Pegger, T
Haager, D
Jamal, N
Heidbuechel, K
author_sort Pegger, T
collection PubMed
description The development of antimicrobial resistance (AMR) is linked to the imprudent use of antimicrobials and is fuelled by industrial farming, accounting for 70% of antimicrobial use. Tackling AMR requires a One Health approach that addresses the root causes of high antimicrobials use in intensive farming and generates co-benefits for human, animal and environmental health. On intensive farms animals are mostly of high-yield breeds and are exposed to stressors, which leads to immunosuppression, increasing susceptibility to infections that need antimicrobial therapy. To combat AMR the EU Commission adopted legislation prohibiting the use of antimicrobials to compensate for poor husbandry and management. However, there is a gap in policy regarding animal welfare improvements necessary to reduce the need for antimicrobials. We assess how the EU animal welfare legislation, under revision, can contribute to filling this gap by providing the regulatory framework for improvements needed to reduce antimicrobial use. Methods include literature review and expert interviews in an approach that integrates knowledge across the human-animal-environmental sectors. Improvements in husbandry and management (lower stocking density, outdoor access, genetic diversity, etc.) positively impact animal health and welfare, consequently reducing susceptibility to infections and antimicrobial use. By prescribing these improvements the revised animal welfare legislation can have a synergistic effect with the Veterinary Products Regulation, in line with the Farm to Fork strategy, and provide the regulatory framework for higher animal welfare standards that reduce antimicrobial use. The positive correlation between higher animal welfare and the reduced need for antimicrobials demonstrates the urgency of improving welfare in farming as a key strategy to limit AMR. It builds the case for an ambitious revision of the EU animal welfare legislation to protect animal and human health in line with One Health. KEY MESSAGES: • The revised EU animal welfare legislation can become a relevant policy in tackling AMR by providing the regulatory framework for high animal welfare standards neded to reduce antimicrobials in farming. • Tackling AMR requires a One Health approach addressing the root causes of high antimicrobial use in intensive farming: the poor welfare of animals, which increases their susceptibility to infections.
format Online
Article
Text
id pubmed-10595174
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105951742023-10-25 How the EU animal welfare legislation can tackle AMR – a One Health perspective Pegger, T Haager, D Jamal, N Heidbuechel, K Eur J Public Health Parallel Programme The development of antimicrobial resistance (AMR) is linked to the imprudent use of antimicrobials and is fuelled by industrial farming, accounting for 70% of antimicrobial use. Tackling AMR requires a One Health approach that addresses the root causes of high antimicrobials use in intensive farming and generates co-benefits for human, animal and environmental health. On intensive farms animals are mostly of high-yield breeds and are exposed to stressors, which leads to immunosuppression, increasing susceptibility to infections that need antimicrobial therapy. To combat AMR the EU Commission adopted legislation prohibiting the use of antimicrobials to compensate for poor husbandry and management. However, there is a gap in policy regarding animal welfare improvements necessary to reduce the need for antimicrobials. We assess how the EU animal welfare legislation, under revision, can contribute to filling this gap by providing the regulatory framework for improvements needed to reduce antimicrobial use. Methods include literature review and expert interviews in an approach that integrates knowledge across the human-animal-environmental sectors. Improvements in husbandry and management (lower stocking density, outdoor access, genetic diversity, etc.) positively impact animal health and welfare, consequently reducing susceptibility to infections and antimicrobial use. By prescribing these improvements the revised animal welfare legislation can have a synergistic effect with the Veterinary Products Regulation, in line with the Farm to Fork strategy, and provide the regulatory framework for higher animal welfare standards that reduce antimicrobial use. The positive correlation between higher animal welfare and the reduced need for antimicrobials demonstrates the urgency of improving welfare in farming as a key strategy to limit AMR. It builds the case for an ambitious revision of the EU animal welfare legislation to protect animal and human health in line with One Health. KEY MESSAGES: • The revised EU animal welfare legislation can become a relevant policy in tackling AMR by providing the regulatory framework for high animal welfare standards neded to reduce antimicrobials in farming. • Tackling AMR requires a One Health approach addressing the root causes of high antimicrobial use in intensive farming: the poor welfare of animals, which increases their susceptibility to infections. Oxford University Press 2023-10-24 /pmc/articles/PMC10595174/ http://dx.doi.org/10.1093/eurpub/ckad160.081 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Parallel Programme
Pegger, T
Haager, D
Jamal, N
Heidbuechel, K
How the EU animal welfare legislation can tackle AMR – a One Health perspective
title How the EU animal welfare legislation can tackle AMR – a One Health perspective
title_full How the EU animal welfare legislation can tackle AMR – a One Health perspective
title_fullStr How the EU animal welfare legislation can tackle AMR – a One Health perspective
title_full_unstemmed How the EU animal welfare legislation can tackle AMR – a One Health perspective
title_short How the EU animal welfare legislation can tackle AMR – a One Health perspective
title_sort how the eu animal welfare legislation can tackle amr – a one health perspective
topic Parallel Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595174/
http://dx.doi.org/10.1093/eurpub/ckad160.081
work_keys_str_mv AT peggert howtheeuanimalwelfarelegislationcantackleamraonehealthperspective
AT haagerd howtheeuanimalwelfarelegislationcantackleamraonehealthperspective
AT jamaln howtheeuanimalwelfarelegislationcantackleamraonehealthperspective
AT heidbuechelk howtheeuanimalwelfarelegislationcantackleamraonehealthperspective